Viewing Study NCT00481520


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT00481520
Status: COMPLETED
Last Update Posted: 2009-09-30
First Post: 2007-05-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-06
Start Date Type: None
Primary Completion Date: 2008-01
Primary Completion Date Type: ACTUAL
Completion Date: 2008-01
Completion Date Type: ACTUAL
First Submit Date: 2007-05-30
First Submit QC Date: None
Study First Post Date: 2007-06-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2009-09-30
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2009-09-28
Last Update Post Date: 2009-09-30
Last Update Post Date Type: ESTIMATED